Friday, 09 Apr 2021 | Funding Deadline
The Translational Grant aims to support and accelerate the translation of research discoveries into potential new treatments to protect and regenerate hearing and /or silence tinnitus. It funds projects at both academic institutions and small/medium enterprises in any country.
RNID are looking for research proposals that will advance the development of small molecule, gene or cell-based therapeutics for the treatment of hearing disorders, including tinnitus. They seek to support research with a strong commercial potential that is likely to attract follow-on funding at the conclusion of the grant, and studies that will facilitate and enable the progression of promising basic research towards testing in clinical trials.
Deadline for proposals: 9th April 2021
Find out more here